Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

12.20
Delayed Data
As of Aug 26
 -0.51 / -4.01%
Today’s Change
7.86
Today|||52-Week Range
20.58
-17.79%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$863.1M

Company Description

Momenta Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products. It focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune disease. It sells its products include Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.

Contact Information

Momenta Pharmaceuticals, Inc.
675 West Kendall Street
Cambridge Massachusetts 02142
P:(617) 491-9700
Investor Relations:
(617) 395-5189

Employees

Shareholders

Mutual fund holders48.47%
Other institutional40.12%
Individual stakeholders20.65%

Top Executives

Craig A. WheelerPresident, CEO & Class II Director
Matthew P. OttmerChief Operating Officer
Richard P. SheaChief Financial Officer & Senior Vice President
Ganesh Venkataraman KaundinyaChief Scientific Officer & Senior VP-Research
James M. RoachChief Medical Officer & Senior VP-Development